<?xml version="1.0" encoding="UTF-8" standalone="no"?><information><Cell><NavigationPath><Head00>Patient</Head00><Stub><StubValue>6</StubValue></Stub><HeaderValue>EULAR response criteria</HeaderValue></NavigationPath><value>Good</value><CellType>Text</CellType></Cell><Table><TableType>Matrix</TableType><tableName>Clinical data of patients</tableName><tableOrder>Table 1</tableOrder><tableFooter>DMARD, disease-modifying antirheumatic drug; EULAR, European League Against Rheumatism; NA, not available; RA, rheumatoid arthritis.aThe scoring system is described in Materials and methods, Additional immunohistochemical data for patient 10.</tableFooter></Table><Document><DocumentTitle>Effect of infliximab on mRNA expression profiles in synovial tissue of rheumatoid arthritis patients</DocumentTitle><PMC>1794525</PMC></Document></information>